Acrodermatitis chronica atrophicans: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 8: | Line 8: | ||
==[[Acrodermatitis chronica atrophicans overview|Overview]]== | ==[[Acrodermatitis chronica atrophicans overview|Overview]]== | ||
==[[Acrodermatitis chronica atrophicans historical perspective|Historical Perspective]]== | ==[[Acrodermatitis chronica atrophicans historical perspective|Historical Perspective]]== | ||
==[[Acrodermatitis chronica atrophicans pathophysiology|Pathophysiology]]== | ==[[Acrodermatitis chronica atrophicans pathophysiology|Pathophysiology]]== | ||
==[[Acrodermatitis chronica atrophicans differential diagnosis|Differentiating Acrodermatitis chronica atrophicans from other Diseases]]== | ==[[Acrodermatitis chronica atrophicans differential diagnosis|Differentiating Acrodermatitis chronica atrophicans from other Diseases]]== | ||
==[[Acrodermatitis chronica atrophicans epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Acrodermatitis chronica atrophicans epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Acrodermatitis chronica atrophicans risk factors|Risk Factors]]== | ==[[Acrodermatitis chronica atrophicans risk factors|Risk Factors]]== | ||
| Line 18: | Line 15: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Acrodermatitis chronica atrophicans history and symptoms|History and Symptoms]] | [[Acrodermatitis chronica atrophicans physical examination|Physical Examination]] | [[Acrodermatitis chronica atrophicans laboratory findings|Laboratory Findings | [[Acrodermatitis chronica atrophicans history and symptoms|History and Symptoms]] | [[Acrodermatitis chronica atrophicans physical examination|Physical Examination]] | [[Acrodermatitis chronica atrophicans laboratory findings|Laboratory Findings]] | [[Acrodermatitis chronica atrophicans other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[Acrodermatitis chronica atrophicans medical therapy|Medical Therapy]] | [[Acrodermatitis chronica atrophicans primary prevention|Primary Prevention]] | [[Acrodermatitis chronica atrophicans secondary prevention|Secondary Prevention]] | [[Acrodermatitis chronica atrophicans cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Acrodermatitis chronica atrophicans future or investigational therapies|Future or Investigational Therapies]] | [[Acrodermatitis chronica atrophicans medical therapy|Medical Therapy]] | [[Acrodermatitis chronica atrophicans primary prevention|Primary Prevention]] | [[Acrodermatitis chronica atrophicans secondary prevention|Secondary Prevention]] | [[Acrodermatitis chronica atrophicans cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Acrodermatitis chronica atrophicans future or investigational therapies|Future or Investigational Therapies]] | ||
Revision as of 19:52, 19 December 2012
For patient information, click here
|
Acrodermatitis chronica atrophicans Microchapters |
|
Differentiating Acrodermatitis chronica atrophicans from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acrodermatitis chronica atrophicans On the Web |
|
American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans |
|
Risk calculators and risk factors for Acrodermatitis chronica atrophicans |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Synonyms and keywords: Pick-Herxheimer disease; Herxheimer disease; primary diffuse atrophy; ACA
Overview
Historical Perspective
Pathophysiology
Differentiating Acrodermatitis chronica atrophicans from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies